Literature DB >> 906456

Electrographic exercise stress testing and coronary arteriography. Correlation among 114 men with chest pain.

W V Vieweg, J S Alpert, A D Johnson, A D Hagan.   

Abstract

The electrocardiographic response to exercise stress testing (EST) was compared with coronary arteriographic findings in 114 men referred for evaluation of chest pain. The men were divided into two groups: group A (69 men) in whom the coronary arteriograms showed at least one major vessel with greater than 70 percent reduction in cross sectional area, and group B (45 men) in whom there was no evidence of coronary arterial narrowing. In both groups A and B the description of chest pain was judged to be at least consistent with the diagnosis of angina pectoris if not always representing classical angina pectoris. Only men with a positive finding to EST and those with a negative EST response after achieving at least 90 percent of predicted maximum heart rate were included in the calculations. Our results were strikingly similar to those obtained from an extensive review of the literature and showed the following: sensitivity, 80.4 percent; specificity, 88.6 percent; predictive value of a positive test result, 91.1 percent; predictive value of a negative test result, 75.6 percent, and efficiency of the test 83.7 percent. The maximal EST is a useful predictor of coronary artery disease when a male population is evaluated for chest pain. When a population is selected on some basis other than chest pain (such as elevated lipids or age), EST is a much less useful predictor of coronary artery disease.

Entities:  

Mesh:

Year:  1977        PMID: 906456      PMCID: PMC1237773     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  11 in total

1.  Letter: Predictive value of laboratory tests.

Authors:  R S Galen
Journal:  Am J Cardiol       Date:  1975-10-06       Impact factor: 2.778

2.  Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease.

Authors:  J S Borer; J F Brensike; D R Redwood; S B Itscoitz; E R Passamani; N J Stone; J M Richardson; R I Levy; S E Epstein
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

3.  Correlation of computer-quantitated treadmill exercise electrocardiogram with arteriographic location of coronary artery disease.

Authors:  P L McHenry; J F Phillips; S B Knoebel
Journal:  Am J Cardiol       Date:  1972-11       Impact factor: 2.778

4.  Maximum treadmill exercise test in patients with abnormal control electrocardiograms.

Authors:  J W Linhart; H B Turnoff
Journal:  Circulation       Date:  1974-04       Impact factor: 29.690

5.  Diagnostic value of clinical history, exercise testing and atrial pacing in patients with chest pain.

Authors:  J Piessens; W Van Mieghem; H Kesteloot; H De Geest
Journal:  Am J Cardiol       Date:  1974-03       Impact factor: 2.778

6.  Correlation of electrocardiographic studies and arteriographic findings with angina pectoris.

Authors:  G C Friesingerg; R F Smith
Journal:  Circulation       Date:  1972-12       Impact factor: 29.690

7.  Maximal treadmill exercise electrocardiography. Correlations with coronary arteriography and cardiac hemodynamics.

Authors:  C M Martin; D R McConahay
Journal:  Circulation       Date:  1972-11       Impact factor: 29.690

8.  Exercise test, history, and serum lipid levels in patients with chest pain and normal electrocardiogram at rest: comparison to findings at coronary arteriography.

Authors:  C A Ascoop; M L Simoons; W G Egmond; A V Bruschke
Journal:  Am Heart J       Date:  1971-11       Impact factor: 4.749

Review 9.  Exercise stress testing in evaluation of patients with ischemic heart disease.

Authors:  R A Bruce; T R Hornsten
Journal:  Prog Cardiovasc Dis       Date:  1969-03       Impact factor: 8.194

10.  Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms.

Authors:  M H Sketch; S M Mohiuddin; J D Lynch; A E Zencka; V Runco
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.